oh oh oh! great N = 1 provoking experiment! I am thinking about you looking at the plate :))))))
there was a huge calorie deficit and I suppose you continue exercise :))) this is the lipid energy model in practice! hope you are well !!!!!!! curious about Dave! and my N = 1 adding more calories in my diet
Hi Nick! I've been following your work on LMHR with interest. I'm glad you and the others are studying this further, because I think I'm a classic LMHR, but I'm not happy w my ApoB nor my NMR lipoprofile. It's encouraging that the first round of CCTAs in your study showed no correlation between high LDL and plaque formation, and I assume the 1 yr follow-up CCTAs are in the works. Do you have any plans to study any of the other biomarkers for ASCVD risk, like ApoB, small particle LDL, etc?
p.s. I'd be happy to contribute to your data set. Prefer not to post my actual numbers here, but happy to share privately if it would be helpful to you and your research partners.
Yes the 1-year data are under review. And, yes, we emphasize findings on ApoB and also have data on sm LDL, Lp(a) etc. See here: https://www.youtube.com/watch?v=OTjxonsKLCM
oh oh oh! great N = 1 provoking experiment! I am thinking about you looking at the plate :))))))
there was a huge calorie deficit and I suppose you continue exercise :))) this is the lipid energy model in practice! hope you are well !!!!!!! curious about Dave! and my N = 1 adding more calories in my diet
LEM in practice indeed. You'll love Dave's replication.
Hi Nick! I've been following your work on LMHR with interest. I'm glad you and the others are studying this further, because I think I'm a classic LMHR, but I'm not happy w my ApoB nor my NMR lipoprofile. It's encouraging that the first round of CCTAs in your study showed no correlation between high LDL and plaque formation, and I assume the 1 yr follow-up CCTAs are in the works. Do you have any plans to study any of the other biomarkers for ASCVD risk, like ApoB, small particle LDL, etc?
p.s. I'd be happy to contribute to your data set. Prefer not to post my actual numbers here, but happy to share privately if it would be helpful to you and your research partners.
Yes the 1-year data are under review. And, yes, we emphasize findings on ApoB and also have data on sm LDL, Lp(a) etc. See here: https://www.youtube.com/watch?v=OTjxonsKLCM
Thx, Nick!
Welcome :)